The World Health Organisation (WHO) has prequalified the first diagnostic test for glucose-6-phosphate dehydrogenase (G6PD) deficiency, a critical tool for safely administering WHO-recommended treatments to prevent relapse of Plasmodium vivax (P. vivax) malaria.
Trending
- Plantain price swings hit Lagos traders, consumers
- Federal supplies enable cheaper dialysis at ATBUTH
- Officials call for stronger WASH efforts to eliminate trachoma
- Gombe plans to turn faecal waste into fertiliser
- Group urges increased funding for cervical cancer efforts
- GOVMAIL adoption grows across Nigeria’s public sector
- SAFE strategy helps Eritrea eliminate trachoma, WHO says
- AMR: 173 countries have action plans, but only 22% fully fund and implement them
